all AI news
Gen AI and quantum to design new drugs: Paris-based Aqemia completes €60m Series A
Jan. 30, 2024, 5 a.m. | Daphné Leprince-Ringuet
Latest from Sifted sifted.eu
The French biotech combines generative AI with quantum-inspired algorithms to “invent” new molecules that can target certain diseases
Gen AI and quantum to design new drugs: Paris-based Aqemia completes €60m Series A
ai and quantum algorithms biotech deals design diseases drugs french gen gen ai generative molecules paris quantum series series a
More from sifted.eu / Latest from Sifted
ETH spinoff Mimic raises $2.5m for AI-powered robotic hands
3 days, 6 hours ago |
sifted.eu
Which are the most ‘data-driven’ VCs in Europe?
4 days, 3 hours ago |
sifted.eu
CEE gets a new AI Chamber to represent the interest of AI startups
2 weeks, 2 days ago |
sifted.eu
Jobs in AI, ML, Big Data
Artificial Intelligence – Bioinformatic Expert
@ University of Texas Medical Branch | Galveston, TX
Lead Developer (AI)
@ Cere Network | San Francisco, US
Research Engineer
@ Allora Labs | Remote
Ecosystem Manager
@ Allora Labs | Remote
Founding AI Engineer, Agents
@ Occam AI | New York
AI Engineer Intern, Agents
@ Occam AI | US